EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors

Hejin Jeong, Sophie C Yue, David C Kaelber, Rishi P Singh, Katherine E Talcott

Ophthalmology Retina · 2026-07 · 10 (7) · 734-744

DOI: 10.1016/j.oret.2026.02.019 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2026-07. Verfasst von Hejin Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Clev…. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Protein Kinase Inhibitors, Retinal Artery Occlusion, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NCATS NIH HHS, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Vein OcclusionProtein Kinase InhibitorsRetinal Artery OcclusionNeoplasmsHumansRetrospective StudiesFemaleMaleRisk FactorsAgedMiddle AgedFollow-Up StudiesIncidenceUnited StatesTyrosine Kinase InhibitorsRisk Assessment

Stichwörter der Autor:innen

Anti-VEGFRetinal artery occlusionRetinal vascular occlusionRetinal vein occlusionTyrosine kinase inhibitors.

Substanzen

Protein Kinase InhibitorsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Case Western Reserve University School of Medicine, Cleveland, Ohio; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Center for Clinical Informatics Research and Education, MetroHealth System, Cleveland, Ohio; Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University…
  • Mass Eye and Ear, Mass General Brigham, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
  • Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Cole Eye Institute, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve Univ…

Förderung

  • NEI NIH HHS
  • NCATS NIH HHS
  • Research to Prevent Blindness
  • National Institutes of Health
  • Cleveland Eye Bank Foundation
  • Case Western Reserve University Clinical and Translational Science Collaborative
  • National Center for Advancing Translational Sciences

Zitieren

APA

Jeong, H., Yue, S. C., Kaelber, D. C., Singh, R. P., & Talcott, K. E. (2026). Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 10(7), 734-744. https://doi.org/10.1016/j.oret.2026.02.019

Vancouver

Jeong H, Yue SC, Kaelber DC, Singh RP, Talcott KE. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina. 2026;10(7):734-744. doi:10.1016/j.oret.2026.02.019

BibTeX
@article{Jeong2026,
  author = {Jeong, Hejin and Yue, Sophie C and Kaelber, David C and Singh, Rishi P and Talcott, Katherine E},
  title = {Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors},
  journal = {Ophthalmology Retina},
  year = {2026},
  volume = {10},
  number = {7},
  pages = {734--744},
  doi = {10.1016/j.oret.2026.02.019}
}
Kostenlos starten →